Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-15T04:59:01.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study's Locations section was updated: numerous new sites were added across the United States and internationally (including Belgium, France, Germany, Korea, Spain, and the United Kingdom) and several existing sites were removed, expanding and reorganizing where the trial is conducted.
    Difference
    3%
    Check dated 2025-12-24T16:44:21.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no visible changes to the study details content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:52:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The government funding and NIH operating status notice was removed from the page; core trial details such as study plan, locations, and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:03:11.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now shows an expanded list of study locations and updated contact details. The core study design, eligibility criteria, and outcome measures appear unchanged.
    Difference
    0.2%
    Check dated 2025-11-03T01:26:31.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    - Updated notice about government funding lapse and current operating status with links to official sources. - Version bumped from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-05T10:30:13.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.